BioPharma Credit PLC (BPCR) — Long-term Investment Intensity
BioPharma Credit PLC (BPCR) has a Long-term Investment Intensity of 96.9% as of December 2024. Long-term investments of $1.16 Billion represent 96.9% of total assets of $1.20 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See BioPharma Credit PLC shareholders equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
BioPharma Credit PLC Long-term Investment Intensity (2017–2024)
This chart shows how BioPharma Credit PLC's Long-term Investment Intensity has evolved across 8 annual periods from 2017 to 2024. As of December 2024, the intensity stands at 96.9%, reflecting long-term investments of $1.16 Billion against total assets of $1.20 Billion USD. Also explore BioPharma Credit PLC assets under control for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for BioPharma Credit PLC (2017–2024)
The table below presents the year-by-year Long-term Investment Intensity for BioPharma Credit PLC from 2017 to 2024, covering 8 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see BioPharma Credit PLC market cap and net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 96.9% | $1.16 Billion | $1.20 Billion | ▲ +8.3 pp |
| 2023 | 88.5% | $1.20 Billion | $1.36 Billion | ▼ -1.2 pp |
| 2022 | 89.7% | $1.22 Billion | $1.36 Billion | ▼ -2.7 pp |
| 2021 | 92.4% | $1.27 Billion | $1.37 Billion | ▲ +6.3 pp |
| 2020 | 86.1% | $1.19 Billion | $1.39 Billion | ▲ +8.0 pp |
| 2019 | 78.1% | $1.12 Billion | $1.43 Billion | ▲ +5.8 pp |
| 2018 | 72.3% | $1.01 Billion | $1.39 Billion | ▲ +10.7 pp |
| 2017 | 61.5% | $569.63 Million | $925.49 Million | — |